UNH vs CVS
UNH and CVS side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | CVSCVS HEALTH Corp |
|---|---|---|
| Market cap | $386.92B | $137.12B |
| P/E (TTM) | 32.1 | 47.1 |
| P/B | 11.72 | 1.77 |
| P/S | 0.9x | 0.3x |
| Dividend yield | 2.05% | — |
| Revenue | $449.71B(TTM) | $407.90B(TTM) |
| Revenue growth (YoY) | 11.8% | 7.8% |
| Net income | $12.04B(TTM) | $2.93B(TTM) |
| Earnings growth (YoY) | -16.3% | -61.7% |
| EPS, diluted | $13.28(TTM) | $2.28(TTM) |
| EBIT margin | 4.2% | 1.2% |
| ROE | 36.5% | 2.3% |
| ROIC | 19.9% | 2.9% |
| Piotroski F | — | 6/9 |
| 1y total return | +50.8% | +73.9% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: UNH frente a CVS
| Métrica | UNH | CVS |
|---|---|---|
| Valor final | $40.4K | $14.5K |
| Retorno total | +304.3% | +45.0% |
| CAGR | +14.5% | +3.7% |
| Volatilidad | 29.9% | 28.6% |
| Sharpe | 0.48 | 0.14 |
| Sortino | 0.66 | 0.19 |
| Caída máxima | -61.4% | -56.8% |
Basado en 2600 días de negociación comunes, 2016-03-15 → 2026-07-17 · tasa libre de riesgo 3.85% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)